We are live on
!
Find out more
PG
Pendal Group Portfolio holdings
AUM
$11.6B
1-Year Est. Return
12.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.65%
1 Year Est. Return
-12.87%
3 Year Est. Return
+52.75%
5 Year Est. Return
+103.82%
10 Year Est. Return
–
AUM
$12.1B
AUM Growth
+$1.2B
(+11%)
Cap. Flow
+$1.49B
Cap. Flow
% of AUM
12.26%
Top 10 Holdings %
Top 10 Hldgs %
30.95%
Holding
675
New
129
Increased
199
Reduced
220
Closed
109
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$463M |
| 2 |
Alibaba
BABA
|
+$168M |
| 3 |
UnitedHealth
UNH
|
+$142M |
| 4 |
Linde
LIN
|
+$136M |
| 5 |
Check Point Software Technologies
CHKP
|
+$129M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$115M |
| 2 |
Medpace
MEDP
|
+$115M |
| 3 |
Oracle
ORCL
|
+$112M |
| 4 |
MKS Inc
MKSI
|
+$99.1M |
| 5 |
Aramark
ARMK
|
+$92.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.61% |
| 2 | Healthcare | 16.66% |
| 3 | Financials | 15.34% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Communication Services | 7.86% |
Similar funds
RCAMU
GG
AIM
AAM
PCA
ZCA
GJIC
SBL
Pendal Group's Q3 2021 Portfolio in Review
As of Q3 2021, Pendal Group held 675 positions worth $12.1B, up 11% from $10.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Pendal Group deployed $1.49B of net new capital in Q3 2021, opening 129 new positions and adding to 199 existing holdings. Its largest new stake was BioNTech: 1,455,825 shares worth $397M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Medpace, an estimated $115M trimmed.
- Pendal Group's largest Q3 2021 buy was BioNTech: 1,455,825 shares worth $397M.
- Pendal Group added most to Alibaba in Q3 2021, an estimated $168M increase.
- Pendal Group's biggest Q3 2021 reduction was Medpace, cutting an estimated $115M.
- Pendal Group fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $115M.
- Pendal Group's ten largest holdings make up 31% of its $12.1B portfolio in Q3 2021.
- Pendal Group opened 129 new positions and closed 109 in Q3 2021.
- Pendal Group's portfolio value rose 11% quarter-over-quarter to $12.1B.
Based on Pendal Group's 13F filing for Q3 2021, filed 5 Nov 2021.